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The role of basic fibroblast growth factor (bFGF) in the proliferation and differentiation of rat bone marrow cells in 
culture was studied. bFGF stimulated [3H]thymidine incorporation into these cells by 4-fold at a concentration of 0.3 
ng/ml and half-maximal effect was observed at a concentration of 15 pg/ml. In addition to its mitogenic effect, bFGF 
stimulated alkaline phosphatase activity by 3.6-fold. Continuous treatment with bFGF (for 21 days) resulted in a 6.3-fold 
increase in the culture dish surface area covered by bone-like mineralized tissue. Maximal bone-like tissue formation was 
observed in the presence of 3 ng/ml bFGF with half-maximal effect at a concentration of 0.3 ng/ml. These results indicate 
the possible role of bFGF in the proliferation of osteogenic rat bone marrow cells and their differentiation into cells 
of osteoblast-like phenotype. 
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1. INTRODUCTION 
Growth factors were isolated from bone tissue 
[l] and shown to affect the biologic activity of 
osteogenic cells obtained from fetal and neonatal 
calvaria. Epidermal growth factor was shown to in- 
duce bone cell proliferation with concomitant in- 
hibition of differentiation into bone nodules [2]. 
Transforming growth factor-p stimulated bone cell 
proliferation, bone collagen synthesis [3,4] and 
alkaline phosphatase activity [5], and its binding 
was enhanced by parathyroid hormone [6]. Basic 
and acidic fibroblast growth factors (FGF) were 
shown to stimulate bone cell proliferation but not 
to stimulate their differentiation and capacity to 
produce mineralized bone-like nodules in vitro 
[1,7-91. Isolated bone marrow cells (BMC) from 
adult animals were shown to have osteogenic pro- 
perties when cultured in vivo in diffusion chambers 
[lo]. It was recently reported that these cells have 
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the capacity to produce bone-like nodules in 
culture in the presence of dexamethasone [ 111. The 
present study was aimed to assess the effect of basic 
FGF (bFGF) on the proliferation and differentia- 
tion of bone marrow cells in culture. 
2. MATERIALS AND METHODS 
2.1. Culture model 
Isolation and cultivation of rat BMC were carried out as 
described [ll]. Briefly, femurs of adult Charles River rats 
(40-45 day old) were removed and the marrow flushed out using 
5 ml of culture medium. The released cells from each femur were 
collected in a 75 cm* plastic culture flask (Nunc, Roskilde, Den- 
mark) containing 10 ml complete medium comprising (Y- 
minimal essential medium (cuMEM) supplemented with 15% 
fetal calf serum, glutamine (2 mM), penicillin (100 U/ml), strep- 
tomycin (lOO,ug/ml), and fungizone (0.25 @g/ml) (Biological In- 
dustries, Beth Haemek, Israel), Na-,&glycerophosphate (10 
mM), ascorbic acid (50 /g/ml) and dexamethasone (lo-’ M) 
(Sigma Chemical Co., St. Louis, MO). The cultures were wash- 
ed every second day to remove unattached blood cells. After 1 
week the BMC were trypsinized (trypsin/verssen; Biological In- 
dustries), counted and seeded in 35 mm plastic dishes or 24 wells 
plates (Nunc) at a density of 4 x 104 cells/dish or 1 x 104 
cells/well, respectively. 
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2.2. ?HJThymidine incorporation 
Cells were seeded in 24 wells plates in complete medium. 
After 24 h the medium was replaced by the same complete 
medium containing either 5% or 15% serum. Cultures were in- 
cubated for 24 h, then bFGF (prepared as described [12]) in 
(uMEM containing 0.5% crystallized bovine serum albumin 
(Schwarz/Mann, Cambridge, MA) and [‘Hlthymidine (1 
&i/ml, 42 Ci/mmol; American Radiolabelled Chemicals, Inc., 
St. Louis, MO) were added, and the cultures were incubated for 
another 24 h. At the end of the labelling period, the cultures 
were washed (10 times) with Dulbecco’s modified phosphate 
buffered saline (PBS), lysed in 0.5 ml of 0.1 M NaOH and the 
radioactivity in each well was determined by a Packard liquid 
scintillation counter (Packard Instrument Company, Downers 
Grove, IL). [3H]Thymidine incorporation was expressed as 
cpm/mg protein. Protein concentration was determined accor- 
ding to Lowry [13]. 
2.3. Alkaline phosphatase activity 
Two-week-old cultures in 35 mm culture dishes in the absence 
or presence of bFGF (added every other day) were extracted into 
1 ml of 10 mM Tris-HCl (pH 7.6) containing 0.1% Triton X-100 
and 10 mM MgC12 and stored at - 20°C [14]. Alkaline 
phosphatase activity was determined using an alkaline 
phosphatase reagent kit (Trace Scientific Pty. Ltd., Baulkham 
Hills, Australia). Enzyme activity was expressed as U/mg pro- 
tein. 
2.4. Measurements of mineralized bone-like tissue 
Three-week-old cultures maintained in 35 mm culture dishes 
in the absence or presence of bFGF (added every other day) were 
fixed for 24 h with a solution of formalin:methanol: water 
(1: 1: 1.5, v/v) and stained for 15 min with a saturated solution 
of Alizarin Red S (PH 4.0) (BDH Chemicals Ltd., Poole, 
England). The dishes were washed with water and dried. The 
dish area covered with a heavy red stain representing calcified 
tissue was then measured with an image analysis system (Quan- 
timet 900, Cambridge Instruments; Cambridge, England). The 
effect of bFGF was tested in each of the above mentioned assays 
in the range 0.01-10 ng/ml. In each experiment four 
dishes/wells were assessed for each concentration of bFGF. 
3. RESULTS 
3.1. Effect of bFGF on L3H]thymidine 
incorporation 
In the presence of 5% fetal calf serum, cell pro- 
liferation was limited and the addition of bFGF on- 
ly slightly enhanced [‘Hlthymidine incorporation. 
In the presence of 15% fetal calf serum, dose- 
dependent stimulation with maximum stimulation 
of 4.1-fold at bFGF concentration of 0.3 ng/ml 
and half-maximal effect at a concentration of 15 
pM was observed (fig.1). 
3.2. Alkaline phosphatase activity 
Alkaline phosphatase was assessed in lCday-old 
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Fig.1. Effect of bFGF on [3H]thymidine incorporation in rat 
bone marrow cells in the presence of 5% (0) or 15% (0) fetal 
calf serum. 
cultures following the initiation of nodule forma- 
tion. bFGF at a concentration of 0.1 ng/ml or 
lower did not affect alkaline phosphatase activity, 
but higher concentrations of bFGF increased the 
specific activity of alkaline phosphatase in the 
cultures and maximal stimulation of 3.6-fold was 
observed at bFGF concentration of 3 ng/ml (fig.2). 
3.3. Mineralized bone-like nodule formation 
Mineralized bone-like nodules were detected in 
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Fig.2. Effect of bFGF on alkaline phosphatase activity. 
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21-day-old cultures by Alizarin Red as heavily 
stained areas that were measured and expressed as 
a percentage of the culture dish surface (fig.3). 
bFGF at a concentration range of 0.1-10 ng/ml, 
stimulated the appearance of mineralized tissue in 
a dose-dependent manner with maximum stimula- 
tion of 6.2-fold at a concentration of 3 ng/ml. At 
10 ng/ml, a slight decrease in the mineralization 
was observed, concomitant with a decrease in 
alkaline phosphatase activity (figs.2 and 3). 
4. DISCUSSION 
The bone marrow culture system used in the pre- 
sent study has been shown to produce bone-like 
tissue in vitro as characterized by collagen typing, 
osteocalcin and osteonectin identification and the 
hydroxyapatite nature of the deposited mineral [ 111. 
[3H]Thymidine uptake in BMC was stimulated 
by bFGF only in the presence of a high concentra- 
tion (15%) of fetal calf serum. Maximal effect of 
bFGF on thymidine uptake was achieved at a con- 
centration of 0.3 ng/ml. Similar results were ob- 
tained with fetal calf calvaria cells [9], but only in 
the presence of TGFfi as a potentiating factor. 
Previous studies showed that the stimulatory ef- 
fect of growth factors on bone cell proliferation 
was associated with either a decrease [1,8] or a 
limited stimulation of the phenotypic expression of 
these cells [ 151. bFGF was found to have a 
mitogenic effect on calvaria cells and to increase 
the osteocalcin content of the conditioned media, 
but mineralized bone-like nodule formation occur- 
red only after removal of bFGF from the medium 
Fig.3. Quantitative mineralized tissue in rat bone marrow de- 
rived cultures. 
[9]. In the present study, bFGF is shown, for the 
first time, to play a major inductive role in the pro- 
liferation and differentiation of bone marrow cells 
obtained from adult animals. This was indicated by 
the increase in alkaline phosphatase activity and 
particularly by the enhanced formation of bone- 
like mineralized tissue in vitro. Both alkaline 
phosphatase activity and mineralization were max- 
imal in the presence of 3 ng/ml of bFGF, whereas 
maximal proliferation was obtained at a concentra- 
tion of 0.3 ng/ml. These findings suggest that 
bFGF may induce both proliferation and differen- 
tiation of bone cells in culture through separate 
pathways each of which require different bFGF 
concentrations. The increase in mineralized bone 
nodule formation in the presence of bFGF (3 
ng/ml) probably represents the combination of two 
processes: enhancement of the proliferation of the 
osteoprogenitor cell population and stimulation of 
the differentiation of this population into cells that 
express an osteoblastic phenotype. 
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